RESMED INC — Director's Dealing 2014

May 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-05-13

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-13	ResMed Common Stock	M	18000	$23.875	Acquired	31000	Direct
2014-05-13	ResMed Common Stock	S	18000	$51.00	Disposed	13000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-13	ResMed Stock Options	$23.875	M	18000	Disposed	2016-07-07	ResMed Common Stock (18000)	Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.

F2: This transaction was executed in multiple trades at prices ranging from $51.00 to $51.01. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.